Showing results (31-40 of 102) with videos related to
Sort By:
Pageof 11
Cytokine|July 2, 2002
Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSFCristina Gasparetto, Maura Gasparetto, Michael Morse, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2002
Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cellsNelson J Chao, Cong X Liu, Barbara Rooney, et al.Therapeutics and Clinical Risk Management|January 19, 2017
A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumabMary Lou Affronti, Sarah Woodring, Katherine B Peters, et al.American Journal of Medical Genetics. Part A|March 19, 2016
Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1Roy E Strowd, Fausto J Rodriguez, Roger E McLendon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancerWilliam P Petros, Gloria Broadwater, Donald Berry, et al.Journal of Neuro-Oncology|May 21, 2013
O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphomaXiaoyin Jiang, David A Reardon, Annick Desjardins, et al.The Oncologist|May 31, 2015
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable GlioblastomaKatherine B Peters, Emil Lou, Annick Desjardins, et al.Journal of Neuro-Oncology|July 8, 2011
A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant gliomaAnnick Desjardins, David A Reardon, Katherine B Peters, et al.Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplantsMichael A Morse, David Rizzieri, Timothy T Stenzel, et al.International Journal of Radiation Oncology, Biology, Physics|April 15, 2011
Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomasKyle C Cuneo, James J Vredenburgh, John H Sampson, et al.Pageof 11